| Literature DB >> 25587705 |
Alessandra Ravidà1, Luca Musante1, Marjut Kreivi1, Ilkka Miinalainen1, Barry Byrne1, Mayank Saraswat1, Michael Henry2, Paula Meleady2, Martin Clynes2, Harry Holthofer1.
Abstract
Diabetic nephropathy often progresses to end-stage kidney disease and, ultimately, to renal replacement therapy. Hyperglycemia per se is expected to have a direct impact on the biosynthesis of N- and O-linked glycoproteins. This study aims to establish the link between protein glycosylation and progression of experimental diabetic kidney disease using orthogonal methods. Kidneys of streptozotocin-diabetic and control rats were harvested at three different time points post streptozotocin injection. A panel of 12 plant lectins was used in the screening of lectin blots. The lectins UEAI, PHA-E, GSI, PNA, and RCA identified remarkable disease-associated differences in glycoprotein expression. Lectin affinity chromatography followed by mass spectrometric analyses led to the identification of several glycoproteins involved in salt-handling, angiogenesis, and extracellular matrix degradation. Our data confirm a substantial link between glycosylation signature and diabetes progression. Furthermore, as suggested by our findings on dipeptidyl peptidase-IV, altered protein glycosylation may reflect changes in biochemical properties such as enzymatic activity. Thus, our study demonstrates the unexplored potential of protein glycosylation analysis in the discovery of molecules linked to diabetic kidney disease.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25587705 DOI: 10.1038/ki.2014.387
Source DB: PubMed Journal: Kidney Int ISSN: 0085-2538 Impact factor: 10.612